Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2013 by Yale University
Emory University
Massachusetts General Hospital
Seattle Children's Hospital
University of California, Los Angeles
Information provided by (Responsible Party):
Yale University Identifier:
First received: October 29, 2010
Last updated: July 30, 2013
Last verified: July 2013
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2014
  Estimated Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)